- Home
- AMRC vs SGP Comparison
AMRC vs SGP Comparison
Compare AMRC & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMRC | SGP |
|---|---|---|
| Founded | 2000 | 2019 |
| Country | United States | United States |
| Employees | 1601 | N/A |
| Industry | Engineering & Construction | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 968.0M |
| IPO Year | 2010 | 2026 |
Fundamental Metrics
Financial Performance| Metric | AMRC | SGP |
|---|---|---|
| Price | $21.00 | $26.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 6 |
| Target Price | $42.70 | ★ $44.00 |
| AVG Volume (30 Days) | ★ 511.3K | 103.5K |
| Earning Date | 11-02-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,769,928,000.00 | N/A |
| Revenue This Year | $10.39 | N/A |
| Revenue Next Year | $8.43 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.38 | $17.06 |
| 52 Week High | $44.93 | $30.56 |
Technical Indicators
Market Signals| Indicator | AMRC | SGP |
|---|---|---|
| Relative Strength Index (RSI) | 38.64 | 47.04 |
| Support Level | $20.37 | $25.00 |
| Resistance Level | $24.15 | $26.68 |
| Average True Range (ATR) | 0.98 | 1.57 |
| MACD | -0.25 | -0.44 |
| Stochastic Oscillator | 6.38 | 38.54 |
Price Performance
Historical ComparisonAbout AMRC Ameresco Inc.
Ameresco Inc is an energy infrastructure solutions provider dedicated to helping customers reduce costs, enhance resilience, and decarbonize to net zero in the energy transition. Its comprehensive portfolio includes implementing smart energy efficiency solutions, upgrading aging infrastructure, and developing, constructing, and operating distributed energy resources. Its solutions range from upgrades to facility's energy infrastructure to the development, construction and operation of renewable energy plants combined with tailored financial solutions. Its segments include North America Regions, U.S. Federal, Renewable Fuels, Europe, and Others. The majority of the revenue is derived from North America Regions segment.
About SGP SpyGlass Pharma Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.